Merit Medical Systems Inc MMSI

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

MMSI hizo una división de acciones (split) de 5:4 el 6 de mayo de 2011: cada 4 acciones se convirtieron en 5. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• Zacks Investment Research 2 oct

  Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex

  The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, and technology adoption, with the global market expected to reach $318.77 billion by 2031. However, tariffs, commodity inflation, and policy-driven pricing changes present headwinds. Five key stocks—McKesson, Cardinal Health, Becton Dickinson, Merit Medical Systems, and ProDex—are highlighted as well-positioned to capitalize on favorable industry trends through 2026.

  

• Zacks Investment Research 1 oct

  5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve

  The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, AI automation, and aging demographics. The global medical supplies market is expected to reach $318.77 billion by 2031 with a 10% CAGR. However, tariffs, commodity inflation, and pharmaceutical pricing changes remain headwinds. Key industry players show mixed near-term prospects with the industry trading at favorable valuations compared to broader markets.

  

• Zacks Investment Research 2 sept

  Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

  Merit Medical Systems (MMSI), a Zacks Rank #2 (Buy) company, is well-positioned for growth driven by its broad medical device portfolio, R&D investments, and the WRAPSODY renal therapy opportunity showing strong clinical outcomes. However, the company faces headwinds from tariffs expected to reduce 2026 results by $16 million (21 cents per share) and intense competition in the medical device space.

  

• GlobeNewswire Inc. 19 jun

  Microcatheter Market Size to Reach USD 1.79 Billion by 2035 | SNS Insider

  The global microcatheter market is valued at USD 1.05 billion in 2025 and is projected to reach USD 1.79 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by increasing adoption of minimally invasive cardiovascular and neurovascular procedures, rising prevalence of cardiovascular and neurovascular disorders, and advancements in catheter technologies. Aspiration microcatheters lead with 36% market share, while steerable microcatheters are the fastest-growing segment. North America dominates with 34% of global revenues, with Asia-Pacific emerging as the fastest-growing region.